Profluent
Data as of .
Company facts
-
Founded
2022
-
Headquarters
United States (Emeryville, CA)
-
Total funding
$150M
Latest funding round
- Round
- Financing
- Date
- Nov 19, 2025
- Amount
- $106M
- Lead investor
- Altimeter Capital and Bezos Expeditions (co-leads)
Drug discovery partners
2 pharma, 1 other. Pharma here means a company with approved products and roughly $1B or more in annual revenue.
-
BioMarin Pharma
Partnership,
Terms not disclosed
-
Eli Lilly Pharma
Research collaboration and license,
$2.25B total potential (upfront not disclosed)
-
Ensoma Biotech
Base editor collaboration,
Terms not disclosed
Recent news
-
Partnership with BioMarin to design novel medicines with Profluent AI models
-
Eli Lilly partnership to design recombinases for genetic medicine, valued at up to $2.25B before royalties
-
Strategic collaboration with Ensoma on AI-designed base editors
-
Financing: $106M
-
Partnership with IDT on AI-designed enzymes
Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.
Spot an error? Tell me and I'll fix it.